Author’s response: Viral load decline time offers theoretical insight rather than practical value

References

1. Jonnerby J, Fenn J, Hakki S, Zhou J, Madon KJ, Koycheva A, et al. Inferring transmission risk of respiratory viral infection from the viral load kinetics of SARS-CoV-2, England, 2020 to 2021 and influenza A virus, Hong Kong, 2008 to 2012. Euro Surveill. 2025;30(6).  https://doi.org/10.2807/1560-7917.ES.2025.30.6.2400234  PMID: 39949319 
2. Dabisch PA, Sanjak JS, Boydston JA, Yeager J, Herzog A, Biryukov J, et al. Comparison of Dose-Response Relationships for Two Isolates of SARS-CoV-2 in a Nonhuman Primate Model of Inhalational COVID-19. J Aerosol Med Pulm Drug Deliv. 2022;35(6):296-306.  https://doi.org/10.1089/jamp.2022.0043  PMID: 36318785 
3. Watson JM, Francis JN, Mesens S, Faiman GA, Makin J, Patriarca P, et al. Characterisation of a wild-type influenza (A/H1N1) virus strain as an experimental challenge agent in humans. Virol J. 2015;12(1):13.  https://doi.org/10.1186/s12985-015-0240-5  PMID: 25645025 
4. Marks M, Millat-Martinez P, Ouchi D, Roberts CH, Alemany A, Corbacho-Monné M, et al. Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study. Lancet Infect Dis. 2021;21(5):629-36.  https://doi.org/10.1016/S1473-3099(20)30985-3  PMID: 33545090 
5. Bhavnani D, James ER, Johnson KE, Beaudenon-Huibregtse S, Chang P, Rathouz PJ, et al. SARS-CoV-2 viral load is associated with risk of transmission to household and community contacts. BMC Infect Dis. 2022;22(1):672.  https://doi.org/10.1186/s12879-022-07663-1  PMID: 35931971 
6. Lee LYW, Rozmanowski S, Pang M, Charlett A, Anderson C, Hughes GJ, et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity by Viral Load, S Gene Variants and Demographic Factors, and the Utility of Lateral Flow Devices to Prevent Transmission. Clin Infect Dis. 2022;74(3):407-15.  https://doi.org/10.1093/cid/ciab421  PMID: 33972994 
7. Mitjà O, Corbacho-Monné M, Ubals M, Alemany A, Suñer C, Tebé C, et al. A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19. N Engl J Med. 2021;384(5):417-27.  https://doi.org/10.1056/NEJMoa2021801  PMID: 33289973 
8. Petrie JG, Ohmit SE, Cowling BJ, Johnson E, Cross RT, Malosh RE, et al. Influenza transmission in a cohort of households with children: 2010-2011. PLoS One. 2013;8(9):e75339.  https://doi.org/10.1371/journal.pone.0075339  PMID: 24086511